A clinical trial to look at how risdiplam is processed by the body and how safe it is in treatment of very young babies with spinal muscular atrophy
A Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy
-
Muscle And Peripheral Nerve Disease -
Spinal Muscular Atrophy (SMA)
For the latest version of this information please go to www.forpatients.roche.com